ArticleMalaria journal2019

Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties.

Aissata Camara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.